# Romiplostim N01 for Injection for Secondary Prophylaxis of CIT in Breast Cancer

> clinical trial · VERIFIED · 2026-08-18

Status: NOT_YET_RECRUITING · Sponsor: Fudan University · Condition: Thrombocytopenia Chemotherapy Induced

- Company: Fudan University
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07771881

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.